Erytech-SQZ collaboration to ‘realize immune-modulating potential’ 11-Jul-2019 By Maggie Lynch Erytech entered an agreement with SQZ to advance RBC-based therapeutics for immune modulation using the latter’s platform.
Pfizer licenses immune tolerance therapy for type 1 diabetes 07-Mar-2019 By Maggie Lynch Pfizer exercises option from a previous agreement with AnTolRx to license immune tolerance therapy for type 1 diabetes.